drugset / Trial / NCT01549847
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This protocol aims to assess of L-carnitine and piracetam to relieve weakness, muscle fatigue and muscle pain in patients with Postpoliomyelitis Syndrome.
Timeline
- Start
- —
- Primary completion
- 2013-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 990 mg | Oral |
| Subject | Piracetam | Small molecule | 810 mg | Oral |